AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is

The US State Department confirmed that a US Patent and Trademark Office employee has been barred from leaving China, and said officials were working to resolve the situation.